Sex-specific difference in phenotype of Kabuki syndrome type 2 patients: a matched case-control study

• Published in: BMC pediatrics Vol. 24; no. 1; p. 133
• Main Authors: Wang, Yirou, Xu, Yufei, Chen, Yao, Hu, Yabin, Li, Qun, Liu, Shijian, Wang, Jian, Wang, Xiumin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 19.02.2024; BioMed Central; BMC
• Subjects: Age; Analysis; Demographic aspects; Females; Gender differences; Genetic aspects; Genetic testing; Genomics; Genotype & phenotype; Intellectual disabilities; Intelligence tests; Kabuki syndrome; Kabuki syndrome type 2; KDM6A; Males; Mothers; Patients; Pediatrics; Phenotype; Risk factors; Severe intellectual disability; Sex-specific difference; Sexes; Ultrasonic imaging; China; Sex-specific difference; KDM6A; Kabuki syndrome type 2; Severe intellectual disability
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-024-04562-z

Kabuki syndrome (KS) is a monogenic disorder leading to special facial features, mental retardation, and multiple system malformations. Lysine demethylase 6A, (KDM6A, MIM*300128) is the pathogenic gene of Kabuki syndrome type 2 (KS2, MIM#300867), which accounts for only 5%-8% of KS. Previous studies suggested that female patients with KS2 may have a milder phenotype. We summarized the phenotype and genotype of KS2 patients who were diagnosed in Shanghai Children's Medical Center since July 2017 and conducted a 1:3 matched case-control study according to age and sex to investigate sex-specific differences between patients with and without KS2. There were 12 KS2 cases in this study, and 8 of them matched with 24 controls. The intelligence quotient (IQ) score of the case group was significantly lower than that of the control group (P < 0.001). In addition, both the incidence of intellectual disability (ID) (IQ < 70) and moderate-to-severe ID (IQ < 55) were significantly higher in the case group than those in the control group. No sex-specific difference was found in the incidence of ID or moderate-to-severe ID between the female cases and female controls, whereas there was a significant difference between male cases and male controls. Furthermore, the rate of moderate-to-severe ID and congenital heart disease (CHD) was significantly higher in the male group than that in the female group. Our results showed that a sex-specific difference was exhibited in the clinical phenotypes of KS2 patients. The incidence of CHD was higher in male patients, and mental retardation was significantly impaired. However, the female patients' phenotype was mild.